Literature DB >> 27795305

Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia.

Li-Yang Hsu1,2,3, Anucha Apisarnthanarak4, Erum Khan5, Nuntra Suwantarat6, Abdul Ghafur7, Paul Anantharajah Tambyah8.   

Abstract

Carbapenem-resistant Gram-negative bacteria, in particular the Acinetobacter baumannii-calcoaceticus complex and Enterobacteriaceae, are escalating global public health threats. We review the epidemiology and prevalence of these carbapenem-resistant Gram-negative bacteria among countries in South and Southeast Asia, where the rates of resistance are some of the highest in the world. These countries house more than a third of the world's population, and several are also major medical tourism destinations. There are significant data gaps, and the almost universal lack of comprehensive surveillance programs that include molecular epidemiologic testing has made it difficult to understand the origins and extent of the problem in depth. A complex combination of factors such as inappropriate prescription of antibiotics, overstretched health systems, and international travel (including the phenomenon of medical tourism) probably led to the rapid rise and spread of these bacteria in hospitals in South and Southeast Asia. In India, Pakistan, and Vietnam, carbapenem-resistant Enterobacteriaceae have also been found in the environment and community, likely as a consequence of poor environmental hygiene and sanitation. Considerable political will and effort, including from countries outside these regions, are vital in order to reduce the prevalence of such bacteria in South and Southeast Asia and prevent their global spread.
Copyright © 2016 American Society for Microbiology.

Entities:  

Keywords:  Acinetobacter; Enterobacteriaceae; Gram-negative bacteria; South Asia; Southeast Asia; carbapenem resistance; carbapenems; mcr-1

Mesh:

Substances:

Year:  2016        PMID: 27795305      PMCID: PMC5217790          DOI: 10.1128/CMR.masthead.30-1

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  167 in total

1.  Inappropriate use of carbapenems in Thailand: a need for better education on de-escalation therapy.

Authors:  Anucha Apisarnthanarak; Linda M Mundy
Journal:  Clin Infect Dis       Date:  2008-09-15       Impact factor: 9.079

2.  Intercontinental transfer of OXA-181-producing Klebsiella pneumoniae into New Zealand.

Authors:  Deborah A Williamson; Helen Heffernan; Hanna Sidjabat; Sally A Roberts; David L Paterson; Marian Smith; Joshua T Freeman
Journal:  J Antimicrob Chemother       Date:  2011-09-19       Impact factor: 5.790

3.  Prevalence and molecular characterization of Enterobacteriaceae producing NDM-1 carbapenemase at a military hospital in Pakistan and evaluation of two chromogenic media.

Authors:  Kathryn M Day; Shamshad Ali; Irfan Ali Mirza; Hanna E Sidjabat; Anna Silvey; Clare V Lanyon; Stephen P Cummings; Shahid Ahmed Abbasi; Muhammad W Raza; David L Paterson; John D Perry
Journal:  Diagn Microbiol Infect Dis       Date:  2012-12-14       Impact factor: 2.803

4.  Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains containing New Delhi metallo-beta-lactamase isolated from two patients in Vietnam.

Authors:  Tran Huy Hoang; Heiman Wertheim; Nguyen Binh Minh; Tran Nhu Duong; Dang Duc Anh; Tran Thi Lan Phuong; Trinh Hong Son; Hidemasa Izumiya; Makoto Ohnishi; Keigo Shibayama; Nguyen Tran Hien
Journal:  J Clin Microbiol       Date:  2012-10-24       Impact factor: 5.948

5.  Detection of New Delhi metallo-β-lactamase (encoded by blaNDM-1) in Acinetobacter schindleri during routine surveillance.

Authors:  Patrick McGann; Michael Milillo; Robert J Clifford; Erik Snesrud; Lindsay Stevenson; Michael G Backlund; Helen B Viscount; Reyes Quintero; Yoon I Kwak; Michael J Zapor; Paige E Waterman; Emil P Lesho
Journal:  J Clin Microbiol       Date:  2013-04-03       Impact factor: 5.948

6.  OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii.

Authors:  Paul G Higgins; Laurent Poirel; Marlene Lehmann; Patrice Nordmann; Harald Seifert
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191

7.  Antibiotic sensitivity pattern of bacterial pathogens in the intensive care unit of Fatmawati Hospital, Indonesia.

Authors:  Maksum Radji; Siti Fauziah; Nurgani Aribinuko
Journal:  Asian Pac J Trop Biomed       Date:  2011-01

8.  Dissemination of clonal complex 2 Acinetobacter baumannii strains co-producing carbapenemases and 16S rRNA methylase ArmA in Vietnam.

Authors:  Tatsuya Tada; Tohru Miyoshi-Akiyama; Kayo Shimada; Tran Thi Thanh Nga; Le Thi Anh Thu; Nguyen Truong Son; Norio Ohmagari; Teruo Kirikae
Journal:  BMC Infect Dis       Date:  2015-10-15       Impact factor: 3.090

Review 9.  Carbapenem Resistance in Gram-Negative Bacteria: The Not-So-Little Problem in the Little Red Dot.

Authors:  Jocelyn Qi Min Teo; Yiying Cai; Tze-Peng Lim; Thuan Tong Tan; Andrea Lay-Hoon Kwa
Journal:  Microorganisms       Date:  2016-02-16

10.  Emergence of Klebsiella pneumoniae ST273 Carrying blaNDM-7 and ST656 Carrying blaNDM-1 in Manila, Philippines.

Authors:  Andrew Chou; Marylette Roa; Michael A Evangelista; Arielle Kae Sulit; Evelina Lagamayo; Brian C Torres; David C Klinzing; Maria Luisa G Daroy; Josephine Navoa-Ng; Richard Sucgang; Lynn Zechiedrich
Journal:  Microb Drug Resist       Date:  2016-03-31       Impact factor: 3.431

View more
  88 in total

Review 1.  Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations.

Authors:  Fereshteh Ezadi; Abdollah Ardebili; Reza Mirnejad
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

2.  PCR-Dipstick Chromatography for Differential Detection of Carbapenemase Genes Directly in Stool Specimens.

Authors:  Rathina Kumar Shanmugakani; Yukihiro Akeda; Norihisa Yamamoto; Noriko Sakamoto; Hideharu Hagiya; Hisao Yoshida; Dan Takeuchi; Yo Sugawara; Takuya Kodera; Mitsuo Kawase; Warawut Laolerd; Narong Chaihongsa; Pitak Santanirand; Yoshikazu Ishii; Shigeyuki Hamada; Kazunori Tomono
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

3.  Diagnostic Accuracy of BD Phoenix CPO Detect for Carbapenemase Production in 190 Enterobacteriaceae Isolates.

Authors:  Chiou Horng Ong; Lasantha Ratnayake; Michelle L T Ang; Raymond Tzer Pin Lin; Douglas Su Gin Chan
Journal:  J Clin Microbiol       Date:  2018-11-27       Impact factor: 5.948

4.  Environmental pollution with antimicrobial agents from bulk drug manufacturing industries in Hyderabad, South India, is associated with dissemination of extended-spectrum beta-lactamase and carbapenemase-producing pathogens.

Authors:  Christoph Lübbert; Christian Baars; Anil Dayakar; Norman Lippmann; Arne C Rodloff; Martina Kinzig; Fritz Sörgel
Journal:  Infection       Date:  2017-04-26       Impact factor: 3.553

Review 5.  Ten-year narrative review on antimicrobial resistance in Singapore.

Authors:  Alvin Qijia Chua; Andrea Lay-Hoon Kwa; Thean Yen Tan; Helena Legido-Quigley; Li Yang Hsu
Journal:  Singapore Med J       Date:  2019-08       Impact factor: 1.858

Review 6.  Rationalizing antimicrobial therapy in the ICU: a narrative review.

Authors:  Jean-François Timsit; Matteo Bassetti; Olaf Cremer; George Daikos; Jan de Waele; Andre Kallil; Eric Kipnis; Marin Kollef; Kevin Laupland; Jose-Artur Paiva; Jesús Rodríguez-Baño; Étienne Ruppé; Jorge Salluh; Fabio Silvio Taccone; Emmanuel Weiss; François Barbier
Journal:  Intensive Care Med       Date:  2019-01-18       Impact factor: 17.440

Review 7.  Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat.

Authors:  David A Butler; Mark Biagi; Xing Tan; Samah Qasmieh; Zackery P Bulman; Eric Wenzler
Journal:  Curr Infect Dis Rep       Date:  2019-11-16       Impact factor: 3.725

8.  In Vivo Efficacy of Humanized WCK 5222 (Cefepime-Zidebactam) Exposures against Carbapenem-Resistant Acinetobacter baumannii in the Neutropenic Thigh Model.

Authors:  Safa S Almarzoky Abuhussain; Lindsay M Avery; Kamilia Abdelraouf; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

9.  Repurposing Zidovudine in combination with Tigecycline for treating carbapenem-resistant Enterobacteriaceae infections.

Authors:  S M S Ng; J S P Sioson; J M Yap; F M Ng; H S V Ching; J W P Teo; R Jureen; J Hill; C S B Chia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-10       Impact factor: 3.267

10.  Novel Plasmid-Mediated tet(X5) Gene Conferring Resistance to Tigecycline, Eravacycline, and Omadacycline in a Clinical Acinetobacter baumannii Isolate.

Authors:  Liyuan Wang; Dejun Liu; Yuan Lv; Lanqing Cui; Yun Li; Tianmeng Li; Huangwei Song; Yuxin Hao; Jianzhong Shen; Yang Wang; Timothy R Walsh
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.